Class II and IV HDACs function as inhibitors of osteoclast differentiation-Reference-Cited by-同舟云学术

Class II and IV HDACs function as inhibitors of osteoclast differentiation

Published:2017-09-27 Issue:9 Volume:12 Page:e0185441
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Blixt Nicholas C.,Faulkner Bora K.,Astleford Kristina,Lelich Rosemary,Schering Jacob,Spencer Ekaterina,Gopalakrishnan Rajaram,Jensen Eric D.,Mansky Kim C.^ORCID

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Osteoclast differentiation and activation;WJ Boyle;Nature,2003

2. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families;T Suda;Endocr Rev,1999

3. The osteoclast: friend or foe?;DV Novack;Annu Rev Pathol,2008

4. Bone resorption by osteoclasts;SL Teitelbaum;Science,2000

5. The molecular understanding of osteoclast differentiation;M Asagiri;Bone,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances of long non-coding RNAs in osteoclast differentiation and osteoporosis;Pathology - Research and Practice;2024-08

2. Unlocking the potential of histone modification in regulating bone metabolism;Biochimie;2024-08

3. Roles of Histone Deacetylase 4 in the Inflammatory and Metabolic Processes;Diabetes & Metabolism Journal;2024-05-31

4. Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents;Medicinal Chemistry Research;2024-03-27

5. Harnessing osteoimmunity to treat peri-implant inflammatory osteolysis;Materials Advances;2024